|
KIF20B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.96749999970392E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87709999999175E-06 |
| Normal-vs-Stage2 |
4.24699999612699E-08 |
| Normal-vs-Stage3 |
1.57450000004555E-06 |
| Normal-vs-Stage4 |
4.18469999999838E-05 |
| Stage1-vs-Stage2 |
3.415700E-02 |
| Stage1-vs-Stage3 |
5.938200E-01 |
| Stage1-vs-Stage4 |
9.906800E-01 |
| Stage2-vs-Stage3 |
1.161170E-01 |
| Stage2-vs-Stage4 |
8.706000E-02 |
| Stage3-vs-Stage4 |
7.236200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.24709999996353E-06 |
| Normal-vs-AfricanAmerican |
8.396700E-03 |
| Normal-vs-Asian |
1.5339499999989E-05 |
| Caucasian-vs-AfricanAmerican |
5.495400E-01 |
| Caucasian-vs-Asian |
5.285400E-01 |
| AfricanAmerican-vs-Asian |
3.755400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.12979999969498E-07 |
| Normal-vs-Female |
1.35840000003995E-06 |
| Male-vs-Female |
2.335200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.13519999997725E-06 |
| Normal-vs-Age(41-60Yrs) |
1.33809999969259E-07 |
| Normal-vs-Age(61-80Yrs) |
1.85892999999826E-05 |
| Normal-vs-Age(81-100Yrs) |
1.074400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.295980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.632800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.555000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.145400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.626400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.607000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.455200E-01 |
| Classical-VS-Follicular |
2.363300E-04 |
| Classical-VS-Other |
2.374800E-01 |
| Classical-VS-Normal |
2.22399999999512E-05 |
| Tall-VS-Follicular |
6.117300E-03 |
| Tall-VS-Other |
1.698390E-01 |
| Tall-VS-Normal |
2.435900E-03 |
| Follicular-VS-Other |
9.681400E-01 |
| Follicular-VS-Normal |
9.49849998654884E-09 |
| Other-VS-Normal |
1.187950E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.41740000531621E-08 |
| Normal-vs-N1 |
1.77859999994645E-06 |
| N0-vs-N1 |
9.520200E-01 |
|
|
